Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: New.
Zustand: New.
Zustand: New.
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: As New. Unread book in perfect condition.
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 74,58
Anzahl: 3 verfügbar
In den WarenkorbZustand: New.
Anbieter: Books Puddle, New York, NY, USA
Zustand: New. 1st edition NO-PA16APR2015-KAP.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 74,66
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
Anbieter: THE SAINT BOOKSTORE, Southport, Vereinigtes Königreich
EUR 80,10
Anzahl: 1 verfügbar
In den WarenkorbPaperback / softback. Zustand: New. New copy - Usually dispatched within 4 working days. 185.
Verlag: Chapman and Hall/CRC 2022-06, 2022
ISBN 10: 1032338784 ISBN 13: 9781032338781
Sprache: Englisch
Anbieter: Chiron Media, Wallingford, Vereinigtes Königreich
EUR 78,40
Anzahl: 10 verfügbar
In den WarenkorbPF. Zustand: New.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 79,35
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: New.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 101,96
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 236 pages. 9.00x6.00x0.50 inches. In Stock.
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: As New. Unread book in perfect condition.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 158,13
Anzahl: 10 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 168,95
Anzahl: 3 verfügbar
In den WarenkorbZustand: New.
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: New.
Zustand: New.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 177,97
Anzahl: 10 verfügbar
In den WarenkorbZustand: New.
Anbieter: THE SAINT BOOKSTORE, Southport, Vereinigtes Königreich
EUR 178,18
Anzahl: 1 verfügbar
In den WarenkorbHardback. Zustand: New. New copy - Usually dispatched within 4 working days.
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: New.
EUR 157,69
Anzahl: Mehr als 20 verfügbar
In den WarenkorbGebunden. Zustand: New. Statistical Approaches in Oncology Clinical Development : Current Paradigm and Methodological Advancement presents an overview of statistical considerations in oncology clinical trials, both early and late phase of development. It illust.
Anbieter: Mispah books, Redhill, SURRE, Vereinigtes Königreich
EUR 237,01
Anzahl: 1 verfügbar
In den WarenkorbHardcover. Zustand: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Anbieter: PBShop.store US, Wood Dale, IL, USA
PAP. Zustand: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
EUR 81,93
Anzahl: Mehr als 20 verfügbar
In den WarenkorbPAP. Zustand: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Anbieter: moluna, Greven, Deutschland
EUR 65,56
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Statistical Approaches in Oncology Clinical Development : Current Paradigm and Methodological Advancement presents an overview of statistical considerations in oncology clinical trials, both early and late phase of development. It illust.
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. Statistical Approaches in Oncology Clinical Development | Current Paradigm and Methodological Advancement | Satrajit Roychoudhury (u. a.) | Taschenbuch | Einband - flex.(Paperback) | Englisch | 2022 | Chapman and Hall/CRC | EAN 9781032338781 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Statistical Approaches in Oncology Clinical Development : Current Paradigm and Methodological Advancement presents an overview of statistical considerations in oncology clinical trials, both early and late phase of development. It illustrates how novel statistical methods can enrich the design and analysis of modern oncology trials. The authors include many relevant real life examples from the pharmaceutical industry and academia based on their first-hand experience. Along with relevant references, the book highlights current regulatory views.The book covers all aspects of cancer clinical trial starting from early phase development. The early part of the book covers novel phase I dose escalation design, exposure response analysis, and innovative phase II design. This includes early development strategy for cancer immunotherapy trials. The contributors also emphasized the role of biomarker and modern era of precision medicine. The second part focuses on the late stage development. This includes the application of adaptive design, safety analysis, and quality of life (QoL) data analysis. The final part discusses current regulatory perspective and challenges.Features:Covers a wide spectrum of topics related to real-life statistical challenges in oncology clinical trials.Provides a comprehensive overview of novel statistical methods to improve trial design and statistical analysis.Detailed case studies illustrate the real life applications.Satrajit Roychoudhury is a Senior Director and a member of the Statistical Research and Innovation group in Pfizer Inc. Prior to joining; he was a member of Statistical Methodology and consulting group in Novartis. He has 11 years of extensive experience in working with different phases of clinical trial. His area of research includes early phase oncology trials, survival analysis, model informed drug development, and use of Bayesian methods in clinical trials. He is industry co-chair for the ASA Biopharmaceutical Section Regulatory-Industry Workshop and has provided statistical training in major conferences including the Joint Statistical Meetings, ASA Biopharmaceutical Section Regulatory-Industry Workshop, and ICSA Applied Statistics Symposium.Soumi Lahiri has 12 years of extensive experience in working different therapeutic areas. She is the former Director of Biostatistics in Clinical Oncology, GlaxoSmithKline. She has also worked in the oncology division of Novartis Pharmaceutical Company for two years. She is an active member of the ASA Biopharmaceutical section and former chair of the membership committee.